title: Status of PR 934-423, a novel anticonvulsant targeted for generalized tonic/clonic seizures (new designation is FPL 12924AA).
authors.affiliation: Fisons Pharmaceuticals, Rochester, NY 14603.
authors.forename: G C
authors.initials: GC
authors.lastname: Palmer
authors.forename: E W
authors.initials: EW
authors.lastname: Harris
authors.forename: J J
authors.initials: JJ
authors.lastname: Napier
authors.forename: M L
authors.initials: ML
authors.lastname: Stagnitto
authors.forename: G E
authors.initials: GE
authors.lastname: Garske
authors.forename: R C
authors.initials: RC
authors.lastname: Griffith
authors.forename: E A
authors.initials: EA
authors.lastname: Swinyard
mesh_terms: D000081:Acetamides / Q000494:pharmacology* / Q000627:therapeutic use; D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology* / Q000627:therapeutic use; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D051381:Rats; D011919:Rats, Inbred Strains; D012640:Seizures / Q000188:drug therapy
chemical_list: D000081:Acetamides; D000927:Anticonvulsants; C067553:remacemide